NCT06331000View on ClinicalTrials.gov

Effect of One Year Elexacaftor-tezacaftor-ivacaftor Treatment

CompletedOBSERVATIONAL
Enrollment

184

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

February 20, 2025

Study Completion Date

February 24, 2025

Conditions
Cystic Fibrosis
Interventions
DRUG

elexacaftor-tezacaftor-ivacaftor treatment

Effect of one year elexacaftor-tezacaftor-ivacaftor treatment on glucose tolerance abnormalities in adult patients with cystic fibrosis

Trial Locations (1)

67000

Hopitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER